FDA recall D-0650-2024
ProRx LLC · Class II · drug
Product
Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01
Reason for recall
Lack of Assurance of Sterility
Distribution
Nationwide in the USA
Key facts
- Status
- Ongoing
- Initiation date
- 2024-08-22
- Report date
- 2024-09-11
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Exton, PA, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0650-2024